A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma

Am J Clin Oncol. 1983 Jun;6(3):325-6. doi: 10.1097/00000421-198306000-00012.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Azo Compounds / therapeutic use*
  • Colonic Neoplasms / drug therapy*
  • Diazooxonorleucine / adverse effects
  • Diazooxonorleucine / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nausea / chemically induced
  • Rectal Neoplasms / drug therapy*
  • Vomiting / chemically induced

Substances

  • Azo Compounds
  • Diazooxonorleucine